OhmBody introduces wearable neurostimulation device aimed at transforming period care

“We didn’t create OhmBody to help you ‘power through’ your cycle. We created it so you don’t have to,” said Amy Gaston, Vice‑President of Strategic Growth at OhmBody.

Image source: ohmbody.com
WT default author logo
Women's Tabloid News Desk

OhmBody, the women’s wellness arm of Spark Biomedical, has introduced a wearable device that uses vagus and trigeminal nerve stimulation to deliver drug‑free relief from disruptive menstrual symptoms. Announced in Dallas on 7 July 2025, the launch marks a significant step towards non‑invasive, hormone‑free period care.

Developed by scientists, engineers and women with lived experience, the device is designed to work with the body’s own regulatory systems. In clinical evaluations, 88 per cent of participants reported greater comfort, blood loss on day one fell by an average 35 per cent (55 per cent across the whole cycle), and 71 per cent said they felt more emotionally stable.

“We didn’t create OhmBody to help you ‘power through’ your cycle. We created it so you don’t have to,” said Amy Gaston, Vice‑President of Strategic Growth at OhmBody. “No more heating pads, doubling up on protection, planning your wardrobe and your life around your period, and pretending everything is fine. It’s time for smarter period care that moves with you.”

The earpiece delivers low‑frequency pulses to both nerves, helping guide the body from a “fight or flight” state back to “rest and digest”. Dr Navid Khodaparast, Chief Science Officer and co‑founder at Spark Biomedical, explained: “Our research demonstrates that targeted neurostimulation can modulate autonomic nervous system activity to help regulate common menstrual symptoms. OhmBody leverages this science to provide women with a non-invasive, drug- and hormone-free option for restoring balance and relief during their cycle.”

Each OhmBody Starter Kit, priced at $719, includes the battery‑powered stimulator, seven single‑use adhesive earpieces, a connecting cable and set‑up materials. The company plans to provide further information and purchasing options through its website.

About OhmBody


At OhmBody, we believe women’s wellness deserves more—more innovation, more understanding, and more solutions designed specifically for the unique needs of the female body. As the women’s wellness division of Spark Biomedical, a leader in wearable neurostimulation, OhmBody is pioneering a new approach to menstrual health, using advanced wearable neurostimulation to support the body’s natural rhythms. Our team understands the challenges women face—because the majority of us have lived them. With a team of women driving exploration and change in clinical research, design, and innovation, we bring both personal insight and deep scientific expertise to our work. The full OhmBody team of experts is dedicated to creating solutions that work with women’s bodies, not against them. For more information, visit www.ohmbody.com.

Share:

Related Insights

Professor Victoria Cogger named founding head of Sydney Biomedical Accelerator

Fujitsu and DT-Axis partner to accelerate digital health innovation

AI analysis of mammograms identifies hidden heart disease risk in women

Oska Health secures €11 million seed funding to expand AI-led coaching for chronic care in Europe

Global Ovarian Cancer Research Consortium awards first AI Accelerator Grant with Microsoft support

NAMA Talks 2026 to centre on women’s health and quality of life across Sharjah

Expo City Dubai launches FemTech Hub at Women’s Pavilion to drive regional women’s health innovation

SHEIN widens CSR programme in Saudi Arabia with new child health and inclusion partnerships